Skip to main content
OpenTrials

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,005 public trials 529 recruiting studies
Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Recruiting

A Study to Evaluate Safety and Efficacy of Bomedemstat (MK-3543-017)

NCT06351631

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +15 more
Locations
  • University of Michigan ( Site 6000) Ann Arbor, Michigan, United States
  • DUHS Duke Blood Cancer Center ( Site 6005) Durham, North Carolina, United States
  • The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive C ( Site 6007) Columbus, Ohio, United States
  • UPMC Hillman Cancer Center ( Site 6004) Pittsburgh, Pennsylvania, United States
View all 21 locations
View Trial Details
Recruiting

A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia

NCT05304377

Conditions
Bone Marrow Diseases, CML, Chronic Disease, +14 more
Locations
  • Memorial Sloan Kettering Cancer Center New York, United States
  • Montefiore Medical Center The Bronx, New York, United States
  • Oregon Health & Science University-Knight Cardiovascular Institute Portland, Oregon, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View all 45 locations
View Trial Details
Recruiting

A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic Anemia

NCT07499284

Conditions
Anemia, Anemia, Aplastic, Aplastic Anaemia, +4 more
Locations
  • Hematology Department, The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
  • Suzhou Hongci Hematology Hospital Suzhou, Jiangsu, China
  • The Affiliated Hospital of Xuzhou Medical University Xuzhou, Jiangsu, China
  • The First Affiliated Hospital of Zhejiang Chinese Medical University Hangzhou, Zhejiang, China
View Trial Details
Recruiting

Fludarabine Phosphate, Cytarabine, Filgrastim-sndz, Gemtuzumab Ozogamicin, and Idarubicin Hydrochloride in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

NCT00801489

Conditions
Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, +19 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Study on Efficacy and Safety of Givinostat Versus Hydroxyurea in Patients With Polycythemia Vera

NCT06093672

Conditions
Bone Marrow Diseases, Bone Marrow Neoplasms, Hematologic Diseases, +6 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Emad Ibrahim, MD, Inc Redlands, California, United States
  • US Oncology Inc Englewood, Colorado, United States
  • American Oncology Partners of Maryland, PA Bethesda, Maryland, United States
View all 90 locations
View Trial Details

Related conditions